We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Gut Microbes Could Enable Early Detection and Treatment of Pancreatic Cancer

By LabMedica International staff writers
Posted on 13 Jun 2025

Pancreatic cancer remains one of the most serious and challenging diseases in oncology due to its difficulty in detection and limited treatment options. More...

Now, a new international collaborative study suggests that in the future, early-stage pancreatic cancer could potentially be identified through the analysis of gut microbes. These microbes may also present new opportunities for developing therapies.

In this study, researchers from the University of Jyväskylä (Jyväskylä, Finland) and their collaborators analyzed the gut microbiota of over 180 pancreatic cancer patients from Finland and Iran, along with healthy individuals from the same regions. They discovered consistent microbial patterns associated with pancreatic cancer regardless of the patients' geographic or ethnic backgrounds. Compared to the healthy group, the intestinal microbiota of pancreatic cancer patients contained significantly more facultative pathogens and notably fewer beneficial bacteria. Specifically, a decline was observed in helpful bacteria from the Clostridia class, such as the butyric acid–producing Lachnospiraceae, Butyricicoccaceae, and Ruminococcaceae. In contrast, higher levels of potential pathogens like Enterobacteriaceae, Enterococcaceae, and Fusobacteriaceae were found in the gut flora of those with pancreatic cancer.

Based on these findings, the researchers propose that future investigations should explore whether these beneficial microbes could be developed into a new class of probiotics—live microbial products—that could be used alongside standard chemotherapy. This combination could potentially offer a more precise and effective method for treating pancreatic cancer. At the same time, the researchers stress the importance of conducting additional studies in varied populations to validate these results. Furthermore, they created a statistical model using microbiome data, which may eventually assist in predicting pancreatic cancer. This marks a promising initial step toward achieving earlier diagnosis of the disease.

“The findings on beneficial Clostridia are interesting because it has been shown earlier that ordinary Clostridiales populations effectively mediate anti-canceric immune reactions against solid tumors,” said Satu Pekkala, Senior Lecturer from the Faculty of Sport and Health Sciences, University of Jyväskylä.


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Drug Test Kit
DrugCheck 3000
New
Staining System
RAL DIFF-QUIK
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more

Pathology

view channel
Image: A tool uses artificial intelligence and high-resolution imaging to track senescent cells (Courtesy of Adobe Stock)

AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease

Senescent cells, which stop growing and reproducing due to injury, aging, or disease, play a critical role in wound repair and aging-related diseases like cancer and heart disease. These cells, however,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.